You just read:

NeuroVive's new Generation of Sanglifehrin-based Compounds Demonstrate Potent Inhibitory Effects on Human Hepatocellular Cancer Cells

News provided by

NeuroVive Pharmaceutical

02 Feb, 2017, 07:59 GMT